Literature DB >> 7744263

Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.

P H Duesberg1.   

Abstract

Hemophilia-AIDS has been interpreted in terms of two hypotheses: the foreign-protein-AIDS hypothesis and the Human Immunodeficiency Virus (HIV)-AIDS hypothesis. The foreign-protein-AIDS hypothesis holds that proteins contaminating commercial clotting factor VIII cause immunosuppression. The foreign-protein hypothesis, but not the HIV hypothesis, correctly predicts seven characteristics of hemophilia-AIDS: 1) The increased life span of American hemophiliacs in the two decades before 1987, although 75% became infected by HIV--because factor VIII treatment, begun in the 1960s, extended their lives and simultaneously disseminated harmless HIV. After 1987 the life span of hemophiliacs appears to have decreased again, probably because of widespread treatment with the cytotoxic anti-HIV drug AZT. 2) The distinctly low, 1.3-2%, annual AIDS risk of hemophiliacs, compared to the higher 5-6% annual risk of intravenous drug users and male homosexual aphrodisiac drug users--because transfusion of foreign proteins is less immunosuppressive than recreational drug use. 3) The age bias of hemophilia-AIDS, i.e. that the annual AIDS risk increased 2-fold for each 10-year increase in age--because immunosuppression is a function of the lifetime dose of foreign proteins received from transfusions. 4) The restriction of hemophilia-AIDS to immunodeficiency diseases--because foreign proteins cannot cause non-immunodeficiency AIDS diseases, like Kaposi's sarcoma. 5) The absence of AIDS diseases above their normal background in sexual partners of hemophiliacs--because transfusion-mediated immunotoxicity is not contagious. 6) The occurrence of immunodeficiency in HIV-free hemophiliacs--because foreign proteins, not HIV, suppress their immune system. 7) Stabilization, even regeneration, of immunity of HIV-positive hemophiliacs by long-term treatment with pure factor VIII. This shows that neither HIV nor factor VIII plus HIV are immunosuppressive by themselves. Therefore, AIDS cannot be prevented by elimination of HIV from the blood supply and cannot be rationally treated with genotoxic antiviral drugs, like AZT. Instead, hemophilia-AIDS can be prevented and has even been reverted by treatment with pure factor VIII.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744263     DOI: 10.1007/BF01435001

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  107 in total

1.  Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.

Authors:  R Madhok; A Gracie; G D Lowe; A Burnett; K Froebel; E Follett; C D Forbes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

2.  Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort.

Authors:  P Simmonds; D Beatson; R J Cuthbert; H Watson; B Reynolds; J F Peutherer; J V Parry; C A Ludlam; C M Steel
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

3.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

Authors:  J J Goedert; C M Kessler; L M Aledort; R J Biggar; W A Andes; G C White; J E Drummond; K Vaidya; D L Mann; M E Eyster
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

4.  Human immunodeficiency virus-1 disease progression in hemophiliacs.

Authors:  P R Becherer; M L Smiley; T J Matthews; K J Weinhold; C W McMillan; G C White
Journal:  Am J Hematol       Date:  1990-07       Impact factor: 10.047

Review 5.  Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.

Authors:  D K Smith; J J Neal; S D Holmberg
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

6.  A model-based estimate of the mean incubation period for AIDS in homosexual men.

Authors:  K J Lui; W W Darrow; G W Rutherford
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

Review 7.  The impact of clotting factor concentrates on the immune system in individuals with hemophilia.

Authors:  E D Gomperts; R de Biasi; R De Vreker
Journal:  Transfus Med Rev       Date:  1992-01

8.  Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV).

Authors:  R A Sharp; S M Morley; J S Beck; G E Urquhart
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

9.  Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.

Authors:  A N Phillips; C A Sabin; J Elford; M Bofill; G Janossy; C A Lee
Journal:  BMJ       Date:  1994-07-30

10.  Immunologic and virologic status of multitransfused patients: role of type and origin of blood products. By the AIDS-Hemophilia French Study Group.

Authors: 
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

View more
  2 in total

1.  Commentary: non-HIV hypotheses must be studied more carefully.

Authors:  P Duesberg
Journal:  BMJ       Date:  1996-01-27

2.  The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition.

Authors:  Peter Duesberg; Claus Koehnlein; David Rasnick
Journal:  J Biosci       Date:  2003-06       Impact factor: 1.826

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.